Lidings has become an official authorized provider of legal services for Participants and Residents of the Skolkovo Technopark.
On the June, 26th 2018 the Plenum of the Supreme Court of the Russian Federation adopted the Resolution No. 27 “On challenging of the major and interested party transactions” (hereinafter — The Resolution).
Lidings, the leading legal advisor in Russia providing legal support to large national and international companies operating in the pharmaceuticals and healthcare sector in Russia and CIS, launces a series of specialized tests on the legislative regulation of the sector.
Lidings’ Intellectual Property practice Associate Roman Vlasov will run a webinar on GDPR and Russian Business: Application and Enforcement as part of a series of webinars led by experts from the leading law firms and heads of legal of large companies, organized by Pravo.ru.
Draft law designed to adopt electronic employment record books has been prepared by the Russian Ministry of labor (“Draft law”). As of the date of this legal update publication the Draft law undergoes public discussions stage.
Lidings continues to receive recognition from leading international legal directories as top-notch advisor to businesses in the Russian market. International Financial Law Review 1000 (IFLR1000) once again notes Lidings for its expertise M&A and Restructuring and Insolvency practice areas.
Lidings Managing Partner Andrey Zelenin and Partner Stepan Guzey will take part in the Russian Law Week 2018 in London on November 12-14.
Collection of articles in English written by leading Russian experts in the field of dispute resolution. The book is published in Russia under the umbrella of Research and Educational Centre “Law and Business MSU”, Lomonosov Moscow State University Faculty of Law.
Lidings experts authored the following sections: Summary Jurisdiction, Proceedings in Commercial Courts with the Participation of a Foreign Person, Resolving Intellectual Property Disputes and Resolving Labour Disputes.
On October 18, 2018 new wording of the Rules of state registration and re-registration of maximum sale prices established by drug manufacturers for those drugs, that are included in the vital and essential drugs list (“the Rules” and “the Drugs” correspondingly) has been enacted with the amendments introduced by the Russian Government Decree of 08.10.2018 No. 1207 “On amendments to the Russian Government Decree of October, 29 2010 No. 865 and of September, 15 2015 No. 979” (“the Decree”).
Lidings experts have authored the The Pharma Legal Handbook: Russia — practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Russia.
The site uses cookie technology to ensure optimal performance, analyze usage and improve user experience. By continuing to use the site, you consent to the placement of cookies on your device on the terms set out in the Privacy Policy.
To ensure optimal performance, analyze usage and improve user experience, the website may use web analytics systems (including Yandex.Metrica), which may place cookies on your device.
By continuing to use the website, you agree to the use of these technologies and the placement of cookies. You can delete cookies from your device through your browser settings and you can block the placement of cookies, however, in doing so, some website features may not be available due to the engine's technological limitations.
You can find more information in the Privacy Policy.